Across TCGA pan-cancer cohorts, LINC02583 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC02583 data layer compared with 15 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02583 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02583 expression acts as an unfavorable survival marker.

LIHC and UCEC are the cancer types where LINC02583 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Median	All	0.044	0.553	<.001	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC02583 tumor-vs-normal RNA expression · all LINC02583 data types